The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Xifeng Wu

Department of Epidemiology

The University of Texas MD Anderson Cancer Center

1515 Holcombe Blvd

Unit 1340

[email]@mdanderson.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Epidemiology, The University of Texas MD Anderson Cancer Center, 1155 Herman P. Pressler Blvd, Unit 1340. 2003 - 2012
  • Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas M.D. Anderson Cancer Center, Houston, USA. 2012

References

  1. Hepatocellular carcinoma risk prediction model for the general population: the predictive power of transaminases. Wen, C.P., Lin, J., Yang, Y.C., Tsai, M.K., Tsao, C.K., Etzel, C., Huang, M., Hsu, C.Y., Ye, Y., Mishra, L., Hawk, E., Wu, X. J. Natl. Cancer Inst. (2012) [Pubmed]
  2. A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23. Wu, X., Scelo, G., Purdue, M.P., Rothman, N., Johansson, M., Ye, Y., Wang, Z., Zelenika, D., Moore, L.E., Wood, C.G., Prokhortchouk, E., Gaborieau, V., Jacobs, K.B., Chow, W.H., Toro, J.R., Zaridze, D., Lin, J., Lubinski, J., Trubicka, J., Szeszenia-Dabrowska, N., Lissowska, J., Rudnai, P., Fabianova, E., Mates, D., Jinga, V., Bencko, V., Slamova, A., Holcatova, I., Navratilova, M., Janout, V., Boffetta, P., Colt, J.S., Davis, F.G., Schwartz, K.L., Banks, R.E., Selby, P.J., Harnden, P., Berg, C.D., Hsing, A.W., Grubb, R.L., Boeing, H., Vineis, P., Clavel-Chapelon, F., Palli, D., Tumino, R., Krogh, V., Panico, S., Duell, E.J., Quirós, J.R., Sanchez, M.J., Navarro, C., Ardanaz, E., Dorronsoro, M., Khaw, K.T., Allen, N.E., Bueno-de-Mesquita, H.B., Peeters, P.H., Trichopoulos, D., Linseisen, J., Ljungberg, B., Overvad, K., Tjønneland, A., Romieu, I., Riboli, E., Stevens, V.L., Thun, M.J., Diver, W.R., Gapstur, S.M., Pharoah, P.D., Easton, D.F., Albanes, D., Virtamo, J., Vatten, L., Hveem, K., Fletcher, T., Koppova, K., Cussenot, O., Cancel-Tassin, G., Benhamou, S., Hildebrandt, M.A., Pu, X., Foglio, M., Lechner, D., Hutchinson, A., Yeager, M., Fraumeni, J.F., Lathrop, M., Skryabin, K.G., McKay, J.D., Gu, J., Brennan, P., Chanock, S.J. Hum. Mol. Genet. (2012) [Pubmed]
  3. Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy. Wu, X., Ye, Y., Rosell, R., Amos, C.I., Stewart, D.J., Hildebrandt, M.A., Roth, J.A., Minna, J.D., Gu, J., Lin, J., Buch, S.C., Nukui, T., Ramirez Serrano, J.L., Taron, M., Cassidy, A., Lu, C., Chang, J.Y., Lippman, S.M., Hong, W.K., Spitz, M.R., Romkes, M., Yang, P. J. Natl. Cancer Inst. (2011) [Pubmed]
  4. Genome-wide association studies of bladder cancer risk: a field synopsis of progress and potential applications. Wu, X., Hildebrandt, M.A., Chang, D.W. Cancer Metastasis Rev. (2009) [Pubmed]
  5. Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy. Wu, X., Lu, C., Ye, Y., Chang, J., Yang, H., Lin, J., Gu, J., Hong, W.K., Stewart, D., Spitz, M.R. Pharmacogenet. Genomics (2008) [Pubmed]
  6. Interplay between mutagen sensitivity and epidemiological factors in modulatinglung cancer risk. Wu, X., Lin, J., Etzel, C.J., Dong, Q., Gorlova, O.Y., Zhang, Q., Amos, C.I., Spitz, M.R. Int. J. Cancer (2007) [Pubmed]
  7. Genetic polymorphism in bladder cancer. Wu, X., Lin, X., Dinney, C.P., Gu, J., Grossman, H.B. Front. Biosci. (2007) [Pubmed]
  8. Mutagen sensitivity: a genetic predisposition factor for cancer. Wu, X., Gu, J., Spitz, M.R. Cancer Res. (2007) [Pubmed]
  9. Projecting individualized probabilities of developing bladder cancer in white individuals. Wu, X., Lin, J., Grossman, H.B., Huang, M., Gu, J., Etzel, C.J., Amos, C.I., Dinney, C.P., Spitz, M.R. J. Clin. Oncol. (2007) [Pubmed]
  10. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Wu, X., Gu, J., Grossman, H.B., Amos, C.I., Etzel, C., Huang, M., Zhang, Q., Millikan, R.E., Lerner, S., Dinney, C.P., Spitz, M.R. Am. J. Hum. Genet. (2006) [Pubmed]
  11. Mutagen sensitivity has high heritability: evidence from a twin study. Wu, X., Spitz, M.R., Amos, C.I., Lin, J., Shao, L., Gu, J., de Andrade, M., Benowitz, N.L., Shields, P.G., Swan, G.E. Cancer Res. (2006) [Pubmed]
  12. Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. Wu, X., Gu, J., Wu, T.T., Swisher, S.G., Liao, Z., Correa, A.M., Liu, J., Etzel, C.J., Amos, C.I., Huang, M., Chiang, S.S., Milas, L., Hittelman, W.N., Ajani, J.A. J. Clin. Oncol. (2006) [Pubmed]
  13. Joint effect of mutagen sensitivity and insulin-like growth factors in predicting the risk of developing secondary primary tumors and tumor recurrence in patients with head and neck cancer. Wu, X., Gu, J., Dong, Q., Huang, M., Do, K.A., Hong, W.K., Spitz, M.R. Clin. Cancer Res. (2006) [Pubmed]
  14. Cell cycle checkpoints, DNA damage/repair, and lung cancer risk. Wu, X., Roth, J.A., Zhao, H., Luo, S., Zheng, Y.L., Chiang, S., Spitz, M.R. Cancer Res. (2005) [Pubmed]
  15. Pharmacogenetics in esophageal cancer. Wu, X., Lu, C., Chiang, S.S., Ajani, J.A. Semin. Oncol. (2005) [Pubmed]
  16. Serum levels of insulin growth factor (IGF-I) and IGF-binding protein predict risk of second primary tumors in patients with head and neck cancer. Wu, X., Zhao, H., Do, K.A., Johnson, M.M., Dong, Q., Hong, W.K., Spitz, M.R. Clin. Cancer Res. (2004) [Pubmed]
  17. Genetic susceptibility to tobacco-related cancer. Wu, X., Zhao, H., Suk, R., Christiani, D.C. Oncogene (2004) [Pubmed]
  18. Telomere dysfunction: a potential cancer predisposition factor. Wu, X., Amos, C.I., Zhu, Y., Zhao, H., Grossman, B.H., Shay, J.W., Luo, S., Hong, W.K., Spitz, M.R. J. Natl. Cancer Inst. (2003) [Pubmed]
 
WikiGenes - Universities